Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05490134 · ClinicalTrials.gov registry record · Early Phase 1

RM1 Project 1 - tAN Naloxone

A Early Phase 1 study of Analgesia, sponsored by Medical University of South Carolina.

Recruiting
Registry status
Early Phase 1
Development phase
136
Enrollment target
1
Study location

NCT05490134 is a Early Phase 1 study of Analgesia that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 136 participants, above the 86-participant average among 19 other Analgesia trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05490134, a Early Phase 1 study of Analgesia, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
Early Phase 1
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

This two-visit, randomized, double-blind, sham-controlled trial, uses a novel naloxone blockade model in 136 individuals to determine whether the analgesic effects of a 30-minute transcutaneous auricular neurostimulation (tAN) intervention are mediated through a release of endogenous opioids. Analgesic effects of four various stimulation interventions will be measured (auricular vagus, auricular trigeminal, combination, or sham) while varying the type of intravenous (IV) infusion (either naloxone or saline) a participant is administered to determine whether the analgesic effects are mitigated by pharmacological opioid receptor blockade.

Conditions Studied

Interventions

  • DRUG Saline
  • DRUG Naloxone

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2023-03-22
Est. Completion 2027-10-01
Phase Early Phase 1

What the Registry Record Tells You About NCT05490134

The ClinicalTrials.gov registry entry for NCT05490134 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 86-participant average among 19 other Analgesia trials with a reported enrollment target (58% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Analgesia appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT05490134 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT05490134 about?

NCT05490134 is a clinical study titled "RM1 Project 1 - tAN Naloxone". This two-visit, randomized, double-blind, sham-controlled trial, uses a novel naloxone blockade model in 136 individuals to determine whether the analgesic effects of a 30-minute transcutaneous auricular neurostimulation (tAN) intervention are mediated through a release of endogenous opioids. Analge...

What is the current status of trial NCT05490134?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 136 participants. The study started on 2023-03-22. Estimated completion is 2027-10-01.

What conditions does trial NCT05490134 study?

This clinical trial studies the following conditions: Analgesia.

What interventions are being tested in trial NCT05490134?

The interventions under investigation include: Saline (DRUG), Naloxone (DRUG).

Who is sponsoring clinical trial NCT05490134?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05490134 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Analgesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.